Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Vigil Neuroscience (VIGL)

Vigil Neuroscience Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VIGL
DateTimeSourceHeadlineSymbolCompany
19/12/202423:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIGLVigil Neuroscience Inc
14/11/202415:00Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:VIGLVigil Neuroscience Inc
12/11/202412:00GlobeNewswire Inc.Vigil Neuroscience to Present at Upcoming Investor ConferencesNASDAQ:VIGLVigil Neuroscience Inc
07/11/202412:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VIGLVigil Neuroscience Inc
07/11/202412:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIGLVigil Neuroscience Inc
07/11/202412:00GlobeNewswire Inc.Vigil Neuroscience Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:VIGLVigil Neuroscience Inc
05/11/202412:00GlobeNewswire Inc.Vigil Neuroscience to Present at Guggenheim Healthcare Innovation ConferenceNASDAQ:VIGLVigil Neuroscience Inc
09/10/202422:22Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:VIGLVigil Neuroscience Inc
19/09/202421:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VIGLVigil Neuroscience Inc
17/09/202411:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIGLVigil Neuroscience Inc
17/09/202411:00GlobeNewswire Inc.Vigil Neuroscience Announces FDA Has Removed Partial Clinical Hold on VG-3927NASDAQ:VIGLVigil Neuroscience Inc
16/09/202420:05GlobeNewswire Inc.Vigil Neuroscience to Present at Cantor Global Healthcare ConferenceNASDAQ:VIGLVigil Neuroscience Inc
29/08/202411:00GlobeNewswire Inc.Vigil Neuroscience to Present at Upcoming September Investor ConferencesNASDAQ:VIGLVigil Neuroscience Inc
13/08/202411:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VIGLVigil Neuroscience Inc
13/08/202411:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIGLVigil Neuroscience Inc
13/08/202411:00GlobeNewswire Inc.Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:VIGLVigil Neuroscience Inc
12/08/202421:02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:VIGLVigil Neuroscience Inc
01/08/202420:05GlobeNewswire Inc.Vigil Neuroscience Highlights Publication on ALSP Genetic Mutation Prevalence in Neurology GeneticsNASDAQ:VIGLVigil Neuroscience Inc
30/07/202420:05GlobeNewswire Inc.Vigil Presents Data on its Small Molecule TREM2 Agonist Program at 2024 Alzheimer's Association International Conference (AAIC)  NASDAQ:VIGLVigil Neuroscience Inc
24/07/202411:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIGLVigil Neuroscience Inc
24/07/202411:00GlobeNewswire Inc.Vigil Neuroscience Announces Interim Data from its Ongoing Phase 1 Clinical Trial Evaluating VG-3927 in Healthy Volunteers Supporting Continued Development in Alzheimer’s DiseaseNASDAQ:VIGLVigil Neuroscience Inc
18/07/202420:05GlobeNewswire Inc.Vigil Announces Upcoming Presentations on its Small Molecule TREM2 Agonist VG-3927 at the 2024 Alzheimer's Association International ConferenceNASDAQ:VIGLVigil Neuroscience Inc
18/07/202411:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIGLVigil Neuroscience Inc
18/07/202411:00GlobeNewswire Inc.Vigil Neuroscience Provides Update on Clinical Development Strategy to Pursue Potential Accelerated Approval Pathway for Iluzanebart in ALSPNASDAQ:VIGLVigil Neuroscience Inc
27/06/202406:00GlobeNewswire Inc.Vigil Neuroscience Announces $40 Million Strategic Investment from SanofiNASDAQ:VIGLVigil Neuroscience Inc
07/06/202421:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIGLVigil Neuroscience Inc
07/06/202421:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIGLVigil Neuroscience Inc
06/06/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIGLVigil Neuroscience Inc
30/05/202411:05GlobeNewswire Inc.Vigil Neuroscience to Present in Upcoming June Investor ConferencesNASDAQ:VIGLVigil Neuroscience Inc
08/05/202411:40GlobeNewswire Inc.Vigil Neuroscience to Present at The Citizens JMP Life Sciences ConferenceNASDAQ:VIGLVigil Neuroscience Inc
 Showing the most relevant articles for your search:NASDAQ:VIGL